Agglutinating secretory iga preserves intestinal epithelial cell integrity during apical infection by shigella flexneri

Infection and Immunity

Volumn 81, Issue 8, 2013, Pages 3027-3034

  Mathias, Amandine ^a   Longet, Stéphanie ^a   Corthésy, Blaise ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; SECRETORY IMMUNOGLOBULIN;

ACTIN DEPOLYMERIZATION; ANIMAL CELL; ANIMAL CELL CULTURE; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL GROWTH; CELL DEATH; CELL STRAIN CACO 2; CELL STRUCTURE; ENTEROBACTERIACEAE; IMMUNITY; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; SHIGELLA; SHIGELLOSIS; TIGHT JUNCTION;

CACO-2 CELLS; DYSENTERY, BACILLARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN A, SECRETORY; INTESTINAL MUCOSA; MICROSCOPY, ELECTRON, SCANNING; SHIGELLA FLEXNERI; TIGHT JUNCTIONS;

EID: 84880667403     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00303-13     Document Type: Article

References (41)

1. Sansonetti PJ. 2006. The bacterial weaponry: lessons from Shigella. Ann. N. Y. Acad. Sci. 1072:307-312.
2. Wassef JS, Keren DF, Mailloux JL. 1989. Role of M cells in initial antigen uptake and in ulcer formation in the rabbit intestinal loop model of shig-ellosis. Infect. Immun. 57:858-863.
3. Zychlinsky A, Prevost MC, Sansonetti PJ. 1992. Shigella flexneri induces apoptosis in infected macrophages. Nature 358:167-169.
4. Phalipon A, Sansonetti PJ. 1999. Microbial-host interactions at mucosal sites. Host response to pathogenic bacteria at mucosal sites. Curr. Top. Microbiol. Immunol. 236:163-189.
5. Fernandez MI, Pedron T, Tournebize R, Olivo-Marin JC, Sansonetti PJ, Phalipon A. 2003. Anti-inflammatory role for intracellular dimeric im-munoglobulin A byneutralizationof lipopolysaccharide inepithelial cells. Immunity 18:739-749.
6. Mounier J, Vasselon T, Hellio R, Lesourd M, Sansonetti PJ. 1992. Shigella flexneri enters human colonic Caco-2 epithelial cells through the basolateral pole. Infect. Immun. 60:237-248.
7. Perdomo OJ, Cavaillon JM, Huerre M, Ohayon H, Gounon P, Sanon-etti PJ. 1994. Acute inflammation causes epithelial invasion and mucosal destruction in experimental shigellosis. J. Exp. Med. 180:1307-1319.
8. Romero S, Grompone G, Carayol N, Mounier J, Guadagnini S, Prevost MC, Sansonetti PJ, Van Nhieu GT. 2011. ATP-mediated Erk1/2 activation stimulates bacterial capture by filopodia, which precedes Shigella invasion of epithelial cells. Cell Host Microbe 9:508-519.
9. Sakaguchi T, Kohler H, Gu X, McCormick BA, Reinecker HC. 2002. Shigella flexneri regulates tight junction-associated proteins in human intestinal epithelial cells. Cell. Microbiol. 4:367-381.
10. Le-Barillec K, Magalhaes JG, CorcuffE, Thuizat A, Sansonetti PJ, Phalipon A, Di Santo JP. 2005. Roles for T and NK cells in the innate immune response to Shigella flexneri. J. Immunol. 175:1735-1740.
11. Sansonetti PJ, Arondel J, Huerre M, Harada A, Matsushima K. 1999. Interleukin-8 controls bacterial transepithelial translocation at the cost of epithelial destruction in experimental shigellosis. Infect. Immun. 67: 1471-1480.
12. Schultsz C, Qadri F, Hossain SA, Ahmed F, Ciznar I. 1992. Shigella-specific IgAinsalivaofchildren with bacillary dysentery. FEMS Microbiol. Immunol. 4:65-72.
13. Boullier S, Tanguy M, Kadaoui KA, Caubet C, Sansonetti P, Corthésy B, Phalipon A. 2009. Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits. J. Immunol. 183:5879-5885.
14. Cohen D, Block C, Green MS, Lowell G, Ofek I. 1989. Immunoglobulin M, A, and G antibody response to lipopolysaccharide O antigen in symptomatic and asymptomatic Shigella infections. J. Clin. Microbiol. 27:162-167.
15. Islam D, Veress B, Bardhan PK, Lindberg AA, Christensson B. 1997. Quantitative assessment of IgG and IgA subclass producing cells in rectal mucosa during shigellosis. J. Clin. Pathol. 50:513-520.
16. Phalipon A, Michetti P, Kaufmann M, Cavaillon JM, Huerre M, Krae-henbuhl JP, Sansonetti PJ. 1994. Protection against invasion of the mouse pulmonary epithelium by a monoclonal IgA directed against Shi-gella flexneri lipopolysaccharide. Ann. N. Y. Acad. Sci. 730:356-358.
17. Rasolofo-Razanamparany V, Cassel-Beraud AM, Roux J, Sansonetti PJ, Phalipon A. 2001. Predominance of serotype-specific mucosal antibody response in Shigella flexneri-infected humans living in an area of ende-micity. Infect. Immun. 69:5230-5234.
18. Forbes SJ, Bumpus T, McCarthy EA, Corthésy B, Mantis NJ. 2011. Transient suppression of Shigella flexneri type 3 secretion by a protective O-antigen-specific monoclonal IgA. mBio 2:00042-11. doi: 10.1128/mBio.00042-11.
19. Thierry AC, Bernasconi E, Mercenier A, Corthésy B. 2009. Conditioned polarized Caco-2 cell monolayers allow to discriminate for the ability of gut-derived microorganisms to modulate permeability and antigen-induced basophil degranulation. Clin. Exp. Allergy 39:527-536.
20. Rathman M, Jouirhi N, Allaoui A, Sansonetti P, Parsot C, Tran Van Nhieu G. 2000. The development of a FACS-based strategy for the isolation of Shigella flexneri mutants that are deficient in intercellular spread. Mol. Microbiol. 35:974-990.
21. Kadaoui KA, Corthésy B. 2007. Secretory IgA mediates bacterial trans-location to dendritic cells in mouse Peyer's patches with restriction to mucosal compartment. J. Immunol. 179:7751-7757.
22. Phalipon A, Kaufmann M, Michetti P, Cavaillon JM, Huerre M, San-sonetti P, Kraehenbuhl JP. 1995. Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexneri lipo-polysaccharide protects against murine experimental shigellosis. J. Exp. Med. 182:769-778.
23. Phalipon A, Costachel C, Grandjean C, Thuizat A, Guerreiro C, Tanguy M, Nato F, Vulliez-Le Normand B, Bélot F, Wright K, Marcel-Peyre V, Sansonetti PJ, Mulard LA. 2006. Characterization of functional oligosac-charide mimics of the Shigella flexneri serotype 2a O-antigen: implications for the development of a chemically defined glycoconjugate vaccine. J. Immunol. 176:1686-1694.
24. Michetti P, Mahan MJ, Slauch JM, Mekalanos JJ, Neutra MR. 1992. Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect. Im-mun. 60:1786-1792.
25. Favre LI, Spertini F, Corthésy B. 2003. Simplified procedure to recover recombinant antigenized secretory IgA to be used as a vaccine vector. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 786:143-151.
26. Crottet P, Cottet S, Corthésy B. 1999. Expression, purification and biochemical characterization of recombinant murine secretory component: a novel tool in mucosal immunology. Biochem. J. 341:299-306.
27. Crottet P, Corthésy B. 1998. Secretory component delays the conversion of secretory IgA into antigen-binding competent F(ab=)2: a possible implication for mucosal defense. J. Immunol. 161:5445-5453.
28. Cottet S, Corthésy-Theulaz I, Spertini F, Corthésy B. 2002. Microaerophilic conditions permit to mimic in vitro events occurring during in vivo Helicobacter pylori infection and to identify Rho/Ras-associated proteins in cellular signaling. J. Biol. Chem. 277:33978-33986.
29. Sansonetti PJ, Kopecko DJ, Formal SB. 1982. Involvement of a plasmid in the invasive ability of Shigella flexneri. Infect. Immun. 35:852-860.
30. Stubbe H, Berdoz J, Kraehenbuhl JP, Corthésy B. 2000. Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers. J. Immunol. 164:1952-1960.
31. Kim M, Ogawa M, Fujita Y, Yoshikawa Y, Nagai T, Koyama T, Nagai S, Lange A, Fässler R, Sasakawa C. 2009. Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment. Nature 459: 578-582.
32. Kim M, Ogawa M, Mimuro H, Sasakawa C. 2010. Reinforcement of epithelial cell adhesion to basement membrane by a bacterial pathogen as a new infectious stratagem. Virulence 1:52-55.
33. Pedron T, Thibault C, Sansonetti PJ. 2003. The invasive phenotype of Shigella flexneri directs a distinct gene expression pattern in the human intestinal epithelial cell line Caco-2. J. Biol. Chem. 278:33878-33886.
34. Mantis NJ, Rol N, Corthésy B. 2011. Secretory IgA's complex roles in immunity and mucosal homeostasis inthe gut. Mucosal Immunol. 4:603-611.
35. Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. 2008. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl. Acad. Sci. U. S. A. 105:15064-15069.
36. Corthésy B. 2010. Role of secretory immunoglobulin A and secretory component in the protection of mucosal surfaces. Future Microbiol. 5:817-829.
37. Lebreton C, Ménard S, Abed J, Moura IC, Coppo R, Dugave C, Monteiro RC, Fricot A, Traore MG, Griffin M, Cellier C, Malamut G, Cerf-Bensussan N, Heyman M. 2012. Interactions among secretory im-munoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. Gastroenterology 143:698-707.
38. Forbes SJ, Eschmann M, Mantis NJ. 2008. Inhibition of Salmonella enterica serovar Typhimurium motility and entry into epithelial cells by a protective antilipopolysaccharide monoclonal immunoglobulin A antibody. Infect. Immun. 76:4137-4144.
39. Horejs C, Ristl R, Tscheliessnig R, Sleytr UB, Pum D. 2011. Single-molecule force spectroscopy reveals the individual mechanical unfolding pathways of a surface layer protein. J. Biol. Chem. 286:27416-27424.
40. Guttman JA, Finlay BB. 2009. Tight junctions as targets of infectious agents. Biochim. Biophys. Acta 1788:832-841.
41. Phalipon A, Tanguy M, Grandjean C, Guerreiro C, Bélot F, Cohen D, Sansonetti PJ, Mulard LA. 2009. A synthetic carbohydrate-protein conjugate vaccine candidate against Shigellaflexneri 2a infection. J. Immunol. 182:2241-2247.